BG44708A3 - Метод за получаване на спиро-3-хетероазолони - Google Patents

Метод за получаване на спиро-3-хетероазолони

Info

Publication number
BG44708A3
BG44708A3 BG063307A BG6330783A BG44708A3 BG 44708 A3 BG44708 A3 BG 44708A3 BG 063307 A BG063307 A BG 063307A BG 6330783 A BG6330783 A BG 6330783A BG 44708 A3 BG44708 A3 BG 44708A3
Authority
BG
Bulgaria
Prior art keywords
heteroazolones
spyro
preparation
inhibitors
treatment
Prior art date
Application number
BG063307A
Other languages
Bulgarian (bg)
English (en)
Inventor
Christopher Lipinski
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG44708A3 publication Critical patent/BG44708A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG063307A 1982-12-06 1983-12-05 Метод за получаване на спиро-3-хетероазолони BG44708A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06
US06/545,450 US4556670A (en) 1982-12-06 1983-10-28 Spiro-3-hetero-azolones for treatment of diabetic complications

Publications (1)

Publication Number Publication Date
BG44708A3 true BG44708A3 (bg) 1989-01-16

Family

ID=27034944

Family Applications (1)

Application Number Title Priority Date Filing Date
BG063307A BG44708A3 (bg) 1982-12-06 1983-12-05 Метод за получаване на спиро-3-хетероазолони

Country Status (21)

Country Link
US (1) US4556670A (enExample)
EP (1) EP0115133B1 (enExample)
KR (1) KR860001581B1 (enExample)
AU (1) AU545409B2 (enExample)
BG (1) BG44708A3 (enExample)
CA (1) CA1204763A (enExample)
DD (1) DD219482A5 (enExample)
DE (1) DE3379043D1 (enExample)
DK (1) DK558283A (enExample)
ES (1) ES527780A0 (enExample)
FI (1) FI80267C (enExample)
GR (1) GR78787B (enExample)
IE (1) IE56345B1 (enExample)
IL (1) IL70379A (enExample)
NO (1) NO160001C (enExample)
NZ (1) NZ206484A (enExample)
PH (1) PH19622A (enExample)
PL (1) PL142143B1 (enExample)
PT (1) PT77760B (enExample)
RO (1) RO88202B (enExample)
YU (1) YU43557B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4575507A (en) 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
JP2005523314A (ja) 2002-04-18 2005-08-04 ユニバーシティ オブ バージニア パテント ファウンデーション 新規ナトリウムチャンネル遮断化合物
AU2003298889A1 (en) * 2002-12-04 2004-06-23 Merck & Co., Inc. Spirocyclic ureas, compositions containing such compounds and methods of use
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
AU545409B2 (en) 1985-07-11
FI834457A0 (fi) 1983-12-05
YU43557B (en) 1989-08-31
DD219482A5 (de) 1985-03-06
IL70379A (en) 1988-10-31
NO160001B (no) 1988-11-21
FI80267B (fi) 1990-01-31
DK558283A (da) 1984-07-11
ES8601912A1 (es) 1985-11-16
PH19622A (en) 1986-05-30
EP0115133B1 (en) 1989-01-25
PT77760B (en) 1986-05-30
EP0115133A1 (en) 1984-08-08
DE3379043D1 (en) 1989-03-02
KR840006975A (ko) 1984-12-04
RO88202B (ro) 1985-12-31
IE56345B1 (en) 1991-07-03
FI80267C (fi) 1990-05-10
US4556670A (en) 1985-12-03
AU2196883A (en) 1984-06-14
GR78787B (enExample) 1984-10-02
ES527780A0 (es) 1985-11-16
IL70379A0 (en) 1984-03-30
DK558283D0 (da) 1983-12-05
FI834457L (fi) 1984-06-07
PL142143B1 (en) 1987-09-30
NO160001C (no) 1989-03-01
RO88202A (ro) 1985-12-30
YU237183A (en) 1986-02-28
KR860001581B1 (ko) 1986-10-10
PT77760A (en) 1983-12-01
IE832854L (en) 1984-06-06
NO834437L (no) 1984-06-07
CA1204763A (en) 1986-05-20
NZ206484A (en) 1987-07-31
PL244966A1 (en) 1985-05-21

Similar Documents

Publication Publication Date Title
SE7906949L (sv) Nya spiro-oxazolidindioner
IT8322155A0 (it) Procedimento per immobilizzare materie biologiche e composto di materie biologiche adsorbite in vermiculite.
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK173883D0 (da) Substituerede 8-phenylxanthiner
GR900100326A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
FI841161A7 (fi) Yhdiste ja koostumus terapeuttista tai diagnostista käyttöä varten sekä terapeuttinen hoitomenetelmä.
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
BG44708A3 (bg) Метод за получаване на спиро-3-хетероазолони
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
AU7457887A (en) Tetrahydrobenzothiazoles
AU8114387A (en) Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression
PT87079A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors and of pharmaceutical compounds containing them
IT8019122A0 (it) Metodo e composizione per il trattamento di lenti a contatto.
IE811612L (en) Thiazoles
ATE30585T1 (de) Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
IT1143224B (it) Procedimento per la produzione di prolattina umana
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
IT1141147B (it) Procedimento per la produzione di ascorbato ossidasi
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
AU5161579A (en) Therapeutical composition for the treatment of infections